Yanwei Chen

1.1k total citations
59 papers, 635 citations indexed

About

Yanwei Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yanwei Chen has authored 59 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Yanwei Chen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Machine Learning in Materials Science (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Yanwei Chen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Machine Learning in Materials Science (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Yanwei Chen collaborates with scholars based in China, United States and Australia. Yanwei Chen's co-authors include Haixin Yu, Haibo Zhou, Xuechen Chen, Quanyi Wang, Lansheng Zhang, Wen Ai, Caihong Li, Zhengxiang Han, Xia Zheng and Yi Tian and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Yanwei Chen

51 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanwei Chen China 14 286 96 91 90 63 59 635
Xiaosong Qin China 17 233 0.8× 115 1.2× 49 0.5× 38 0.4× 49 0.8× 77 897
Linying Zhou China 15 413 1.4× 98 1.0× 58 0.6× 64 0.7× 73 1.2× 38 796
Shuanshuan Xie China 14 162 0.6× 71 0.7× 184 2.0× 58 0.6× 119 1.9× 51 613
Weitao Chen China 10 181 0.6× 77 0.8× 128 1.4× 84 0.9× 54 0.9× 42 513
Miki Ito Japan 16 355 1.2× 72 0.8× 77 0.8× 60 0.7× 229 3.6× 57 861
Ting Luan China 15 218 0.8× 51 0.5× 83 0.9× 91 1.0× 37 0.6× 61 645
Yuki Hayashi Japan 13 200 0.7× 76 0.8× 83 0.9× 50 0.6× 69 1.1× 30 800
Daishun Liu China 18 300 1.0× 74 0.8× 310 3.4× 79 0.9× 78 1.2× 58 878
Lu Bai China 16 238 0.8× 58 0.6× 63 0.7× 131 1.5× 88 1.4× 63 630

Countries citing papers authored by Yanwei Chen

Since Specialization
Citations

This map shows the geographic impact of Yanwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Chen more than expected).

Fields of papers citing papers by Yanwei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Chen. The network helps show where Yanwei Chen may publish in the future.

Co-authorship network of co-authors of Yanwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanwei Chen. A scholar is included among the top collaborators of Yanwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwei Chen. Yanwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Deshi, et al.. (2025). Research progress and future perspectives of prodrug strategies for immune checkpoint inhibitors in cancer immunotherapy. Critical Reviews in Oncology/Hematology. 214. 104905–104905.
2.
Jiao, Yang, et al.. (2025). Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells. CNS Neuroscience & Therapeutics. 31(2). e70229–e70229. 5 indexed citations
3.
4.
Li, Qianqian, Jian K. Liu, Yanwei Chen, et al.. (2024). Decoding the interplay between m 6 A modification and stress granule stability by live-cell imaging. Science Advances. 10(46). eadp5689–eadp5689. 7 indexed citations
5.
Du, Jie, Yaojun Wang, Tingting Zhao, et al.. (2024). Inhibition of Glycyrrhiza Polysaccharide on Human Cytochrome P450 46A1 in vitro and in vivo: Implications in Treating Neurological Diseases. Current Drug Metabolism. 25(3). 227–234.
6.
Chen, Xuefu, Xinxin Zhang, Yahui Yang, et al.. (2024). Left Ventricular Reverse Remodelling as a Promising Strategy for Resolving Left Ventricular Thrombus. ESC Heart Failure. 11(4). 2214–2222. 2 indexed citations
7.
Luo, Yingjie, Naihong Yan, Wenfang Li, et al.. (2023). An X-ray inactivated vaccine against Pseudomonas aeruginosa Keratitis in mice. Vaccine. 41(32). 4700–4709. 3 indexed citations
8.
Li, Duo, et al.. (2023). Role of long pentraxin PTX3 in cancer. Clinical and Experimental Medicine. 23(8). 4401–4411. 5 indexed citations
9.
Zhang, Qian, Kaifu Zheng, Shihong Zhao, et al.. (2023). Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. Heliyon. 9(10). e21059–e21059. 12 indexed citations
10.
Zhang, Daitao, Yulan Sun, Yang Yang, et al.. (2023). Genetic Features of 84 Genomes of Monkeypox Virus in Recent Circulation — Beijing Municipality, China, 2023. China CDC Weekly. 5(41). 918–921. 4 indexed citations
11.
12.
Dou, Xiangfeng, Daitao Zhang, Xiaojun Zhang, et al.. (2022). Epidemiological Investigation of an Inhalational Anthrax Patient Traveling for Medical Treatment in Beijing Municipality, China, August 2021. China CDC Weekly. 4(1). 4–7. 2 indexed citations
13.
Chen, Wei, Yanwei Chen, Juan Su, et al.. (2021). CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells. Digestive Diseases and Sciences. 67(1). 134–145. 11 indexed citations
15.
Yang, Haizhen, Shuangshuang Zhao, Zheng Zhang, et al.. (2020). The associated factors for spontaneous intranodular hemorrhage of partially cystic thyroid nodules. Medicine. 99(51). e23846–e23846. 5 indexed citations
16.
Wang, Dongli, et al.. (2020). Impact of a quality control circle on the incidence of catheter-associated urinary tract infection: An interrupted time series analysis. American Journal of Infection Control. 48(10). 1184–1188. 8 indexed citations
17.
Mu, Lin, et al.. (2016). β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway. International Journal of Oncology. 49(4). 1427–1436. 44 indexed citations
18.
19.
Xu, Weiwei, et al.. (2012). Prediction of minimally conscious state with somatosensory evoked potentials in long-term unconscious patients after traumatic brain injury. The Journal of Trauma: Injury, Infection, and Critical Care. 72(4). 1024–1030. 17 indexed citations
20.
Zhu, Tingzhun, Yanwei Chen, Yiqun Yao, et al.. (2011). β-Elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. Journal of Neuro-Oncology. 107(2). 307–314. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026